Product Name: Human CD37 Antibody (Naratuximab, Research Use)
Catalog Number: NBR-0016
Target Name: CD37
Trade Name: Naratuximab
Antibody Drug Description: Naratuximab emtansine, an antibody-drug conjugate (ADC) targeting CD37, is a potential new treatment for patients with B-cell malignancies, such as non-Hodgkin’s lymphomas (NHL). Naratuximab emtansine demonstrated evidence of anti-cancer activity in NHL in a Phase 1 monotherapy trial and successfully completed a safety lead-in study in combination with rituximab Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD37
Synonyms: TSPAN26
Target Description: The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains.
Ensembl: ENSG00000104894
Uniprot: P11049